Search

Your search keyword '"Johnson, Christopher N."' showing total 482 results

Search Constraints

Start Over You searched for: Author "Johnson, Christopher N." Remove constraint Author: "Johnson, Christopher N." Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
482 results on '"Johnson, Christopher N."'

Search Results

2. Multiplexed Assays of Variant Effect and Automated Patch Clamping Improve KCNH2-LQTS Variant Classification and Cardiac Event Risk Stratification

7. Dynamics and predicted distribution of an irrupting ‘sleeper’ population: fallow deer in Tasmania

12. Fragment-Based Discovery of a Series of Allosteric-Binding Site Modulators of β‑Glucocerebrosidase.

16. Prognostic Value of Multiplexed Assays of Variant Effect and Automated Patch-clamping forKCNH2-LQTS Risk Stratification

17. KBTBD13 is an actin-binding protein that modulates muscle kinetics

18. KBTBD13 is an actin-binding protein that modulates muscle kinetics

29. Aging-regulated anti-apoptotic long non-coding RNA Sarrah augments recovery from acute myocardial infarction

30. Projecting the dynamics of invading deer with pattern‐oriented modelling to support management decision‐making.

31. A Brief Introduction to Chemical Reaction Optimization

35. Supplementary Figure 3 from ASTX660, a Novel Non-peptidomimetic Antagonist of cIAP1/2 and XIAP, Potently Induces TNFα-Dependent Apoptosis in Cancer Cell Lines and Inhibits Tumor Growth

36. Supplementary Table 1 from ASTX660, a Novel Non-peptidomimetic Antagonist of cIAP1/2 and XIAP, Potently Induces TNFα-Dependent Apoptosis in Cancer Cell Lines and Inhibits Tumor Growth

37. Supplementary Figure 4 from ASTX660, a Novel Non-peptidomimetic Antagonist of cIAP1/2 and XIAP, Potently Induces TNFα-Dependent Apoptosis in Cancer Cell Lines and Inhibits Tumor Growth

38. Data from ASTX660, a Novel Non-peptidomimetic Antagonist of cIAP1/2 and XIAP, Potently Induces TNFα-Dependent Apoptosis in Cancer Cell Lines and Inhibits Tumor Growth

39. Supplementary Materials and Methods from ASTX660, a Novel Non-peptidomimetic Antagonist of cIAP1/2 and XIAP, Potently Induces TNFα-Dependent Apoptosis in Cancer Cell Lines and Inhibits Tumor Growth

40. Supplementary Figure 1 from ASTX660, a Novel Non-peptidomimetic Antagonist of cIAP1/2 and XIAP, Potently Induces TNFα-Dependent Apoptosis in Cancer Cell Lines and Inhibits Tumor Growth

41. Supplementary Table 2 from ASTX660, a Novel Non-peptidomimetic Antagonist of cIAP1/2 and XIAP, Potently Induces TNFα-Dependent Apoptosis in Cancer Cell Lines and Inhibits Tumor Growth

42. Supplementary Figure 2 from ASTX660, a Novel Non-peptidomimetic Antagonist of cIAP1/2 and XIAP, Potently Induces TNFα-Dependent Apoptosis in Cancer Cell Lines and Inhibits Tumor Growth

Catalog

Books, media, physical & digital resources